PHMPharma Mar SA
82.05EUR-0.55%Mkt Cap: 1.55B $P/E: 25.62

Pharma Mar, S.A., a biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, res…

Key Statistics

Company
Market Cap1.55B $
Enterprise Value1.41B $
Revenue (TTM)237.66M $
Gross Profit227.32M $
Net Income (TTM)81.51M $
Revenue/Share13.18 USD
Last Price82.05 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees505
CountryES
SectorHealthcare
IndustryBiotechnology
ISINES0169501022
Valuation
P/E (Trailing)25.62
P/E (Forward)13.13
PEG0.31
EV/EBITDA29.02
EV/Revenue5.95
P/S6.51
P/B5.68
EPS (TTM)3.22
EPS (Forward)6.26
52W Range
64.0044% of range105.20
52W High105.20 EUR
52W Low64.00 EUR
Profitability
Gross Margin94.46%
Oper. Margin-2.83%
EBITDA Margin20.50%
Profit Margin33.87%
ROE29.78%
ROA18.98%
Growth
Revenue Growth-12.00%
Earnings Growth
Cash Flow & Leverage
Operating CF57.75M $
CapEx (TTM)10.19M $
FCF Margin18.75%
FCF Yield2.87%
Net Debt-133.74M $
Net Debt/EBITDA-2.74
Balance Sheet
Debt/Equity0.20
Current Ratio2.85
Quick Ratio2.20
Book Value/Sh14.47 EUR
Cash/Share9.741 EUR
Dividends
Fwd Div Rate1.000 EUR
Trail. Div Rate1.000 EUR
Div. Yield1.22%
5Y Avg Yield
Payout Ratio0.00%
Ex-Div DateJul 8, 2026
Pay Date
Splits
Last Split1:12
Split DateJul 22, 2020
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)104.39 EUR
Upside (mean)+27.2%
Target Range85.50 EUR125.00 EUR
85.50+27.2% to mean125.00
# Analysts9
Ownership
Shares Out.17.32M
Float13.40M
Insiders27.21%
Institutions9.65%
Technical
SMA 5077.30 (+6.2%)
SMA 20082.39 (-0.4%)
Beta0.43
S&P 52W Chg18.16%
Avg Vol (30d)34.23K
Avg Vol (10d)42.91K
Technical Indicators
RSI (14)56.4
MACD1.0636
MACD Signal0.7713
MACD Hist.+0.2922
BB Upper85.21 EUR
BB Middle80.70 EUR
BB Lower76.20 EUR
BB Width11.16%
ATR (14)2.393 EUR
Vol Ratio (20d)1.08x